Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.80% Nasdaq Up0.97%

Echo Therapeutics, Inc. (ECTE)

-NasdaqCM

0.49 Up 0.02(3.39%) May 17, 3:57PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Sep 29, 2012Jun 29, 2012Mar 30, 2012
Total Revenue 23   31   31   31  
Cost of Revenue -   -   -   -  
Gross Profit 23   31   31   31  
Operating Expenses
Research Development3,220  2,139  2,200  1,392  
Selling General and Administrative2,299  1,508  1,335  1,859  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (5,497) (3,617) (3,504) (3,220)
Income from Continuing Operations
Total Other Income/Expenses Net1,682  (559)350  235  
Earnings Before Interest And Taxes(3,815)(4,176)(3,154)(2,986)
Interest Expense3,174  89  0  0  
Income Before Tax(6,988)(4,265)(3,154)(2,986)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(6,988)(4,265)(3,154)(2,986)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (6,988) (4,265) (3,154) (2,986)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (6,988) (4,265) (3,154) (2,986)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.